Electronic Submission of Expedited Safety Reports From IND-Exempt BA/BE Studies Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 1, 2024
April 1, 2024
0ba6f618-8ff9-42f6-a368-058e7fd53088
Related Documents
Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
Guidance DocumentSeptember 26, 2024Center for Drug Evaluation and Research
Providing Over-the-Counter Monograph Submissions in Electronic Format
Guidance DocumentJuly 25, 2024Center for Drug Evaluation and Research
Good ANDA Submission Practices Guidance for Industry
Guidance DocumentJanuary 26, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox